Russell Douglas Hull
Russell Douglas Hull publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #239,305 of 7,710,434 ranked researchers
- Rank in Canada
- #8,186 of 183,316
- Works
- 354
- Citations
- 24k
- Citations per work
- 67.2
What does Russell Douglas Hull research?
Russell Douglas Hull's work is mostly in Medicine (80%), Health Professions (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences29683.5%
- Medicine28480.2%
- Health Professions123.3%
- Everything else5816.5%
- 1Internal Medicine34% of their works
- 2Cardiology and Cardiovascular Medicine22% of their works
- 3Surgery14% of their works
- 4Hematology8% of their works
- 5Emergency Medical Services3% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Heparin-Induced Thrombocytopenia and Thrombosis
- Acute Myocardial Infarction Research
- Diagnosis and Treatment of Venous Diseases
- Central Venous Catheters and Hemodialysis
- Ultrasound in Clinical Applications
Which keywords describe Russell Douglas Hull's research?
The keywords of their largest research topics: Antithrombotic Therapy, Diagnosis, Clinical Practice Guidelines, Pulmonary Embolism, Venous Thromboembolism, Guidelines, Anticoagulant Therapy and Atrial Fibrillation.
- Point-of-Care Ultrasonography
- Central Venous Catheterization
- Varicose Veins
- Myocardial Infarction
- Thrombosis
- Thrombin
- Atrial Fibrillation
- Guidelines
- Pulmonary Embolism
- Diagnosis
- Antithrombotic Therapy
- Clinical Practice Guidelines
- Venous Thromboembolism
- Anticoagulant Therapy
- Protease-Activated Receptors
- Heparin-Induced Thrombocytopenia
- Acute Coronary Syndromes
- Chronic Venous Insufficiency
- Catheter-Related Infections
- Lung Ultrasound
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antithrombotic Therapy3842 topics
- Diagnosis3712 topics
- Clinical Practice Guidelines3492 topics
- Pulmonary Embolism3171 topic
- Venous Thromboembolism3171 topic
- Guidelines1612 topics
- Anticoagulant Therapy1181 topic
- Atrial Fibrillation1181 topic
- Protease-Activated Receptors671 topic
- Thrombin671 topic
- Heparin-Induced Thrombocytopenia541 topic
- Thrombosis541 topic
- Acute Coronary Syndromes431 topic
- Myocardial Infarction431 topic
- Chronic Venous Insufficiency321 topic
- Varicose Veins321 topic
- Catheter-Related Infections311 topic
- Central Venous Catheterization311 topic
- Lung Ultrasound251 topic
- Point-of-Care Ultrasonography251 topic
Where does Russell Douglas Hull work?
Russell Douglas Hull's main affiliation in the publication record is University of Calgary, Canada.
How many publications and citations does Russell Douglas Hull have?
OpenAlex counts 354 works and 23,798 citations for Russell Douglas Hull, an h-index of 72, ranking #239,305 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Russell Douglas Hull. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.